{"resourceType":"ValueSet","id":"3.1","meta":{"versionId":"5","lastUpdated":"2020-10-11T01:00:22.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Cliniwiz Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2020-10-11"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/3.1","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:3.1"}],"version":"20201011","name":"DDimerCPTCodes","title":"D Dimer CPT Codes","status":"active","experimental":false,"date":"2020-10-11T01:00:22-04:00","publisher":"Cliniwiz Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","concept":[{"code":"85378","display":"Fibrin degradation products, D-dimer; qualitative or semiquantitative"},{"code":"85379","display":"Fibrin degradation products, D-dimer; quantitative"},{"code":"85380","display":"Fibrin degradation products, D-dimer; ultrasensitive (eg, for evaluation for venous thromboembolism), qualitative or semiquantitative"}]}]},"expansion":{"identifier":"urn:uuid:52a049ed-fcf9-4444-89e9-932e1d1c8f7d","timestamp":"2023-12-11T03:56:53-05:00","total":3,"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"85378","display":"Fibrin degradation products, D-dimer; qualitative or semiquantitative"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"85379","display":"Fibrin degradation products, D-dimer; quantitative"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"85380","display":"Fibrin degradation products, D-dimer; ultrasensitive (eg, for evaluation for venous thromboembolism), qualitative or semiquantitative"}]}}